The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Celgene
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen

Adverse event (AE) management in patients (pts) with relapsed and refractory multiple myeloma (RRMM) taking pomalidomide (POM) plus low dose-dexamethasone (LoDEX): A pooled analysis from 3 clinical trials.
 
Philippe Moreau
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Meletios A. Dimopoulos
Honoraria - Amgen; Celgene; Janssen; Novartis
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis
 
Paul G. Richardson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Johnson & Johnson; Millennium; Novartis; Oncopeptides
Research Funding - Celgene; Millennium
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - COTA
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Merck; Takeda
 
Antonio Palumbo
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Novartis; Onyx; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx
 
Michele Cavo
No Relationships to Disclose
 
Paolo Corradini
No Relationships to Disclose
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Research Funding - Celgene; Janssen
 
Michel Delforge
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Celgene
 
Peter O'Gorman
Honoraria - Amgen; Celgene; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - Celgene; Janssen
 
Kevin W. Song
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen
 
Lars Axel Sternas
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Teresa Peluso
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Kevin Hong
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jennifer Herring
No Relationships to Disclose
 
Xin Yu
Employment - Celgene
 
Mohamed H. Zaki
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jesus San Miguel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx